Skanska USA Building has been a leader in pharmaceutical construction for more than twenty years and recently the company has been strengthening its client relationships on a global basis. “We have strengthened our commitment to our life sciences clients for 2007 and beyond. In addition to opening two offices in Ireland to exclusively serve biotech and pharmaceutical clients, we have added significant process and project management resources to our organization. Our global life sciences headquarters is centered in Philadelphia, yet we serve our clients through a network of offices and teams strategically located throughout the mainland U.S., Puerto Rico and Europe,” said Philip Southerland, Chief Operating Officer of Skanska Life Sciences group. As testament to its success, Skanska ranks number two in pharmaceutical construction according to Engineering News Record’s Top 400 Contractors Sourcebook 2006.